TScan Therapeutics cuts about 75%

TScan Therapeutics told the Securities and Exchange Commission it has cut approximately 75 percent of its workforce, one of the deepest single reductions disclosed this year, as part of a decision to stop pushing a late-stage clinical program forward.

What the filing says

On September 2, 2026 the company initiated what it calls a prioritization strategy: it will prioritize the preclinical development of its in vivo solid tumour program and pause further enrollment in its Phase 3 ALLOHA-2 study of TSC-101. Under that strategy it implemented a workforce reduction of approximately 75 percent, described in the filing as the Strategic Reorganization, expected to be substantially complete by the end of the fourth quarter of 2026.

The company expects to incur approximately $4.1 million in employee-related costs, consisting primarily of pay continuation and related benefits, substantially all of which will result in future cash expenditures.

The second disclosure in the same filing

The same Form 8-K carries an Item 3.01, notice of delisting or failure to satisfy a continued listing rule. The company says it received written notice on August 27, 2026 from the Listing Qualifications Department of Nasdaq.

Reading the two items together is the point of reading filings rather than headlines. A workforce reduction of this depth, a paused Phase 3 study and a listing notice within a week of each other describe a company conserving cash under pressure, not one rebalancing toward a growth priority. The document says so more clearly than any summary of it would.

What a 75 percent cut means for those affected

At this scale the practical advice changes in one respect: speed matters more than negotiation. A company preserving capital is unlikely to improve a severance offer, and the offer on the table is more likely to be the final one. The immediate priorities are the unemployment claim, which pays from the week it is filed rather than the last day of work, and the health coverage decision, which has a hard 60-day window under both COBRA and the Marketplace.

The first 30 days after a layoff sets out the sequence, and health insurance after a layoff compares the two coverage routes with their costs.

Where the site-level detail would appear

An 8-K names no locations. Where the federal WARN Act applies, a notice filed with the state gives the site, the job titles and the number affected, and the WARN notices tracker links each state's listing. How WARN notices work explains the thresholds, which turn on the size of the employer and the number of people losing their jobs at a single site.

The layoffs tracker records this filing with the other Item 2.05 disclosures, each linked to the document itself.